Affordable Access

Cannabinoids in the management of difficult to treat pain

Authors
Publisher
Dove Press
Publication Date
Keywords
  • Therapeutics And Clinical Risk Management
Disciplines
  • Biology
  • Law
  • Pharmacology

Abstract

Ethan B RussoGW Pharmaceuticals, Vashon, WA, USAAbstract: This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized clinical trials employing cannabinoids in pain treatment. Tetrahydrocannabinol (THC, Marinol®) and nabilone (Cesamet®) are currently approved in the United States and other countries, but not for pain indications. Other synthetic cannabinoids, such as ajulemic acid, are in development. Crude herbal cannabis remains illegal in most jurisdictions but is also under investigation. Sativex®, a cannabis derived oromucosal spray containing equal proportions of THC (partial CB1 receptor agonist) and cannabidiol (CBD, a non-euphoriant, anti-inflammatory analgesic with CB1 receptor antagonist and endocannabinoid modulating effects) was approved in Canada in 2005 for treatment of central neuropathic pain in multiple sclerosis, and in 2007 for intractable cancer pain. Numerous randomized clinical trials have demonstrated safety and efficacy for Sativex in central and peripheral neuropathic pain, rheumatoid arthritis and cancer pain. An Investigational New Drug application to conduct advanced clinical trials for cancer pain was approved by the US FDA in January 2006. Cannabinoid analgesics have generally been well tolerated in clinical trials with acceptable adverse event profiles. Their adjunctive addition to the pharmacological armamentarium for treatment of pain shows great promise.Keywords: cannabinoids, tetrahydrocannabinol, cannabidiol, analgesia, pain management, multiple sclerosis

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Cannabinoids in the management of difficult to tre...

on Therapeutics and Clinical Risk... Feb 01, 2008

Cannabinoids in the management of difficult to tre...

on Therapeutics and clinical risk... February 2008

Cannabinoids and pain management.

on Canadian Journal of Anesthesia... August 2006

Cannabinoids in the treatment of pain

on Annals of General Psychiatry Jan 01, 2010
More articles like this..